WHO defined daily doses versus hospital-adjusted defined daily doses: Impact on results of antibiotic use surveillance

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 12, 2013, Pages 2940-2947

  Haug, Jon Birger ^a   Reikvam, Åsmund ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Ddds; Drug utilization; Methodologies

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFALEXIN; CEFALOTIN; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTIBUTEN; CEFUROXIME; CLOXACILLIN; DICLOXACILLIN; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; PIVAMPICILLIN; PIVMECILLINAM; TOBRAMYCIN; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ARTICLE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; DRUG USE; DRUG UTILIZATION; GENERAL HOSPITAL; HOSPITAL BED; HOSPITAL DISCHARGE; HOSPITAL PATIENT; LENGTH OF STAY; PRACTICE GUIDELINE; PRIVATE HOSPITAL; RECOMMENDED DRUG DOSE; WORLD HEALTH ORGANIZATION;

DDDS; DRUG UTILIZATION; METHODOLOGIES;

ANTI-BACTERIAL AGENTS; DRUG UTILIZATION; EPIDEMIOLOGIC METHODS; HOSPITALS; HUMANS; NORWAY;

EID: 84887541656     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt268     Document Type: Article

References (19)

1. WHO.Introduction to Drug Utilization Research. Chapter 6: Drug Utilization Metrics and Their Applications. 2003. http://www.whocc.no/filearchive/ publications/drug_utilization_research.pdf (12 May 2013, date last accessed).
2. Berrington A. Antimicrobial prescribing in hospitals: be careful what you measure. J Antimicrob Chemother 2010; 65: 163-8.
3. Kuster SP, Ruef C, Ledergerber B et al. Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting. Infection 2008; 36: 549-59.
4. deWith K, Bestehorn H, Steib-BauertM et al. Comparisonofdefinedversus recommended versus prescribed daily doses for measuring hospital antibiotic consumption. Infection 2009; 37: 349-52.
5. Kern WV, deWith K, Steib-Bauert M et al. Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001- 2002. Infection 2005; 33: 333-9.
6. deWith K, Maier L, Steib-Bauert M et al. Trends in antibiotic use at a university hospital: defined or prescribed daily doses? Patient days or admissions as denominator? Infection 2006; 34: 91-4.
7. Muller A, MonnetDL, TalonDet al. Discrepanciesbetweenprescribeddaily dosesandWHOdefineddailydosesof antibacterials atauniversity hospital. Br J Clin Pharmacol 2006; 61: 585-91.
8. WHO. Guidelines for ATC Classification and DDD Assignment. 2011. http:// www.whocc.no/filearchive/publications/2011guidelines.pdf (12May 2013, date last accessed).
9. The Norwegian Board of Health Supervision. Guideline for Hospital Use of Antimicrobial Agents, IK-2737. (In Norwegian). 2001. http://ebookbrowse. com/ik-2737-bruk-av-antibiotika-i-sykehus-tdhrr-1-pdf-d382666006 (6 May 2013, date last accessed).
10. Craig WA. Gentamicin: toxicity. In: Grayson ML, ed. Kucers' The Use of Antibiotics. London: Edward Arnold, 2010; 682-5.
11. The Norwegian Directorate of Health, Norwegian Patient Registry. StatRes: Specialist Health Services. Activities and Services. (In Norwegian). http://www.helsedirektoratet.no/tall-analyse/ventetider-aktivitetsdataspesialisthelsetjenesten/ rapportgenerator/Sider/default.aspx (12 May 2013, date last accessed).
12. Bergman U, Popa C, Tomson Y et al. Drug utilization 90%-a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998; 54: 113-8.
13. Zarb P, Ansari F, Muller A et al. Drug utilization 75% (DU75%) in 17 European Hospitals (2000-2005): results from the ESAC-2 Hospital Care Sub Project. Curr Clin Pharmacol 2011; 6: 62-70.
14. MacKenzie FM, Monnet DL, Gould IM et al. Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals. J Antimicrob Chemother 2006; 58: 657-60.
15. Gbaguidi-Haore H, Dumartin C, L'Heriteau F et al. Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes. J Antimicrob Chemother 2013; 68: 461-70.
16. Filius PM, Liem TB, van der Linden PD et al. An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother 2005; 55: 805-8.
17. Ansari F, Molana H, Goossens H et al. Development of standardized methods for analysis of changes in antibacterial use in hospitals from 18 European countries: the European Surveillance of Antimicrobial Consumption (ESAC) longitudinal survey, 2000-06. J Antimicrob Chemother 2010; 65: 2685-91.
18. Haug JB, Berild D,Walberg M et al. Increased antibiotic use inNorwegian hospitals despite a low antibiotic resistance rate. J Antimicrob Chemother 2011; 66: 2643-6.
19. Aavitsland P, Stormark M, Lystad A. Hospital-acquired infections in Norway: a national prevalence survey in 1991. Scand J Infect Dis 1992; 24: 477-83.